Cargando…

Identification of physicochemical properties that modulate nanoparticle aggregation in blood

Inorganic materials are receiving significant interest in medicine given their usefulness for therapeutic applications such as targeted drug delivery, active pharmaceutical carriers and medical imaging. However, poor knowledge of the side effects related to their use is an obstacle to clinical trans...

Descripción completa

Detalles Bibliográficos
Autores principales: Soddu, Ludovica, Trinh, Duong N, Dunne, Eimear, Kenny, Dermot, Bernardini, Giorgia, Kokalari, Ida, Marucco, Arianna, Monopoli, Marco P, Fenoglio, Ivana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Beilstein-Institut 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136551/
https://www.ncbi.nlm.nih.gov/pubmed/32280579
http://dx.doi.org/10.3762/bjnano.11.44
_version_ 1783518274847244288
author Soddu, Ludovica
Trinh, Duong N
Dunne, Eimear
Kenny, Dermot
Bernardini, Giorgia
Kokalari, Ida
Marucco, Arianna
Monopoli, Marco P
Fenoglio, Ivana
author_facet Soddu, Ludovica
Trinh, Duong N
Dunne, Eimear
Kenny, Dermot
Bernardini, Giorgia
Kokalari, Ida
Marucco, Arianna
Monopoli, Marco P
Fenoglio, Ivana
author_sort Soddu, Ludovica
collection PubMed
description Inorganic materials are receiving significant interest in medicine given their usefulness for therapeutic applications such as targeted drug delivery, active pharmaceutical carriers and medical imaging. However, poor knowledge of the side effects related to their use is an obstacle to clinical translation. For the development of molecular drugs, the concept of safe-by-design has become an efficient pharmaceutical strategy with the aim of reducing costs, which can also accelerate the translation into the market. In the case of materials, the application these approaches is hampered by poor knowledge of how the physical and chemical properties of the material trigger the biological response. Hemocompatibility is a crucial aspect to take into consideration for those materials that are intended for medical applications. The formation of nanoparticle agglomerates can cause severe side effects that may induce occlusion of blood vessels and thrombotic events. Additionally, nanoparticles can interfere with the coagulation cascade causing both pro- and anti-coagulant properties. There is contrasting evidence on how the physicochemical properties of the material modulate these effects. In this work, we developed two sets of tailored carbon and silica nanoparticles with three different diameters in the 100–500 nm range with the purpose of investigating the role of surface curvature and chemistry on platelet aggregation, activation and adhesion. Substantial differences were found in the composition of the protein corona depending on the chemical nature of the nanoparticles, while the surface curvature was found to play a minor role. On the other hand, large carbon nanoparticles (but not small carbon nanoparticles or silica nanoparticles) have a clear tendency to form aggregates both in plasma and blood. This effect was observed both in the presence or absence of platelets and was independent of platelet activation. Overall, the results presented herein suggest the existence of independent modes of action that are differently affected by the physicochemical properties of the materials, potentially leading to vessel occlusion and/or formation of thrombi in vivo.
format Online
Article
Text
id pubmed-7136551
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Beilstein-Institut
record_format MEDLINE/PubMed
spelling pubmed-71365512020-04-10 Identification of physicochemical properties that modulate nanoparticle aggregation in blood Soddu, Ludovica Trinh, Duong N Dunne, Eimear Kenny, Dermot Bernardini, Giorgia Kokalari, Ida Marucco, Arianna Monopoli, Marco P Fenoglio, Ivana Beilstein J Nanotechnol Full Research Paper Inorganic materials are receiving significant interest in medicine given their usefulness for therapeutic applications such as targeted drug delivery, active pharmaceutical carriers and medical imaging. However, poor knowledge of the side effects related to their use is an obstacle to clinical translation. For the development of molecular drugs, the concept of safe-by-design has become an efficient pharmaceutical strategy with the aim of reducing costs, which can also accelerate the translation into the market. In the case of materials, the application these approaches is hampered by poor knowledge of how the physical and chemical properties of the material trigger the biological response. Hemocompatibility is a crucial aspect to take into consideration for those materials that are intended for medical applications. The formation of nanoparticle agglomerates can cause severe side effects that may induce occlusion of blood vessels and thrombotic events. Additionally, nanoparticles can interfere with the coagulation cascade causing both pro- and anti-coagulant properties. There is contrasting evidence on how the physicochemical properties of the material modulate these effects. In this work, we developed two sets of tailored carbon and silica nanoparticles with three different diameters in the 100–500 nm range with the purpose of investigating the role of surface curvature and chemistry on platelet aggregation, activation and adhesion. Substantial differences were found in the composition of the protein corona depending on the chemical nature of the nanoparticles, while the surface curvature was found to play a minor role. On the other hand, large carbon nanoparticles (but not small carbon nanoparticles or silica nanoparticles) have a clear tendency to form aggregates both in plasma and blood. This effect was observed both in the presence or absence of platelets and was independent of platelet activation. Overall, the results presented herein suggest the existence of independent modes of action that are differently affected by the physicochemical properties of the materials, potentially leading to vessel occlusion and/or formation of thrombi in vivo. Beilstein-Institut 2020-04-03 /pmc/articles/PMC7136551/ /pubmed/32280579 http://dx.doi.org/10.3762/bjnano.11.44 Text en Copyright © 2020, Soddu et al. https://creativecommons.org/licenses/by/4.0https://www.beilstein-journals.org/bjnano/termsThis is an Open Access article under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0). Please note that the reuse, redistribution and reproduction in particular requires that the authors and source are credited. The license is subject to the Beilstein Journal of Nanotechnology terms and conditions: (https://www.beilstein-journals.org/bjnano/terms)
spellingShingle Full Research Paper
Soddu, Ludovica
Trinh, Duong N
Dunne, Eimear
Kenny, Dermot
Bernardini, Giorgia
Kokalari, Ida
Marucco, Arianna
Monopoli, Marco P
Fenoglio, Ivana
Identification of physicochemical properties that modulate nanoparticle aggregation in blood
title Identification of physicochemical properties that modulate nanoparticle aggregation in blood
title_full Identification of physicochemical properties that modulate nanoparticle aggregation in blood
title_fullStr Identification of physicochemical properties that modulate nanoparticle aggregation in blood
title_full_unstemmed Identification of physicochemical properties that modulate nanoparticle aggregation in blood
title_short Identification of physicochemical properties that modulate nanoparticle aggregation in blood
title_sort identification of physicochemical properties that modulate nanoparticle aggregation in blood
topic Full Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136551/
https://www.ncbi.nlm.nih.gov/pubmed/32280579
http://dx.doi.org/10.3762/bjnano.11.44
work_keys_str_mv AT sodduludovica identificationofphysicochemicalpropertiesthatmodulatenanoparticleaggregationinblood
AT trinhduongn identificationofphysicochemicalpropertiesthatmodulatenanoparticleaggregationinblood
AT dunneeimear identificationofphysicochemicalpropertiesthatmodulatenanoparticleaggregationinblood
AT kennydermot identificationofphysicochemicalpropertiesthatmodulatenanoparticleaggregationinblood
AT bernardinigiorgia identificationofphysicochemicalpropertiesthatmodulatenanoparticleaggregationinblood
AT kokalariida identificationofphysicochemicalpropertiesthatmodulatenanoparticleaggregationinblood
AT maruccoarianna identificationofphysicochemicalpropertiesthatmodulatenanoparticleaggregationinblood
AT monopolimarcop identificationofphysicochemicalpropertiesthatmodulatenanoparticleaggregationinblood
AT fenoglioivana identificationofphysicochemicalpropertiesthatmodulatenanoparticleaggregationinblood